期刊文献+

人恶性黑素瘤细胞株A375中色素上皮衍生因子基因的突变 被引量:1

Detection of pigment epithelium derived factor gene mutation in a human malignant melanoma cell line A375
原文传递
导出
摘要 目的探讨色素上皮衍生因子(PEDF)基因在恶性黑素瘤细胞系中的突变情况。方法采用聚合酶链反应-单链构象多态性分析(PCR—SSCP)对人恶性黑素瘤细胞株A375和正常人黑素细胞中PEDF基因的所有8个外显子进行突变检测。对SSCP分析有异常泳动条带样本的PCR产物进行DNA测序。结果人恶性黑素瘤细胞株A375的第3到第7外显子都出现DNA泳动变位,其中以外显子5,6最为明显。PEDF基因第5,6外显子均存在突变。第5外显子的突变类型以单个碱基的缺失为主,第6外显子的突变类型则以单个碱基的置换为主。结论PEDF基因的突变可能在恶性黑素瘤的发病中起一定作用。 Objective To detect the mutations of pigment epithelium derived factor (PEDF) gene in a human malignant melanoma cell line A375. Methods A375 cells and control melanocytes obtained from circumcised prepuce were cultured, genomic DNA was extracted from these cells. All eight exons of PEDF gene were scanned by single strand conformation polymorphism analysis ofpolymerase chain reaction products (PCR-SSCP) in both A375 cells and control melanocytes. DNA sequencing was performed for the PCR products separated into electrophoretic bands with altered mobility. Results Altered mobility was observed with SSCP analysis in amplicons of exon 3, 4, 5, 6 and 7, with the most obvious alteration occurred in exon 5 and 6. DNA sequencing revealed mutations in both exon 5 and 6. The common type of mutations was single base-deletion in exon 5 and single base-substitution in exon 6. Conclusion Mutations of PEDF gene may contribute to the development of human malignant melanoma.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2008年第10期680-682,共3页 Chinese Journal of Dermatology
关键词 黑色素瘤 实验性 血管生成抑制剂 基因 色素上皮衍生因子 突变 Melanoma, experimental Angiogenesis inhibitors Genes, PEDF Mutation
  • 相关文献

参考文献5

  • 1张成锋,项蕾红,张勇,李剑,郑志忠.色素痣和恶性黑素瘤组织及A375细胞中色素上皮衍生因子的表达[J].中华皮肤科杂志,2007,40(4):213-216. 被引量:1
  • 2Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium- derived factor with potent neuronal differentiative activity. Exp Eye Res, 1991, 53(3): 411-414.
  • 3Tombran-Tink J, Pawar H, Swaroop A, et al. Localization of the gene for pigment epitheliumderived factor (PEDF) to chromosome 17p13.1 and expression in cultured human retinoblastoma cells. Genomics, 1994, 19(2): 266-272.
  • 4Slavc I, Rodriguez IR, Mazuruk K, et al. Mutation analysis and loss of heterozygosity of PEDF in central nervous system primitive neuroectodermal tumors. Int J Cancer, 1997, 72(2 ): 277-282.
  • 5Sasaki Y, Naishiro Y, Oshima Y, et al. Identification of pigment epithelium-derived factor as a direct target of the p53 family member genes. Oncogene, 2005, 24(32): 5131-5136.

二级参考文献9

  • 1Becerra SP.Structure-function studies on PEDF.A noninhibitory serpin with neurotrophic ativtiy.Adv Exp Med Biol, 1997, 425:223-237.
  • 2Guan M, Yam HF, Su B, et al. Loss of pigment epithelium derived factor expression in glioma progression. J Clin Pathol, 2003, 56(4): 277-282.
  • 3Tombran-Tink J, Chader C-G, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity.Exp Eye Res, 1991.53(3): 411-414.
  • 4Steele FR, Chader GJ,Johnson LV,et al.Pigment epitheliumderived factor.nurotrophic activity and identification as a member of the serine protease inhibitor gene family.Proc Natl Acad Sci USA. 1993,90(4): 1526-1530.
  • 5Tombran-Tink J, Pawar H. Swaroop A, el al. Localization of the gene for pigment epithelium-derived factor(PEDF)to chromosome 17p13.1 and expression in cultured human retinoblatoma cells.Genomics,1994, 19(2): 266-272.
  • 6Crawford SE, Stellmach V, Ranalli M. elderived factor (PEDF) in neuroblastoma : a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci,2001,114(Pt 24):4421-4428.
  • 7Mahtabifard A,Merritt RE,Yamada RE,et al.In vivo gene transfer of pigment epithelium-derived factor inhibits tumor growth in syngeneic murine models of thoracic malianancies .J Thorac Cardiovasc Surg,2003,126(1):28-38.
  • 8Miyagishi D,Ohno-Matsui K,Amagasa T,et al.Regulation of the expression of pigment epithelium-derived factor,an anti-angiogenic factor in human oral squamous cell carcinoma cell lines.Cancer Lett,2003,196(1):77-85.
  • 9Abramson LP,Stellmach V,Doll JA,et al.Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model.J Pediatr Surg,2003,38(3):336-342.

同被引文献9

  • 1Hodi FS, CKDay SJ, McDermott DF, et al. Improved survival withipilimumab in patients with metastatic melanoma. N Engl J Med,2010,363(8): 711-723.
  • 2Kong Y, Si L, Guo J, et al. Aberrations of KIT, BRAF, NRAS, andPDGFRA in Chinese melanoma patients and their significance:Large, scale analysis of 644 patients. J Clin Oncol, 2011, 29(15): 8568.
  • 3Ellerhorst JA, Greene VR,Ekmekcioglu S,et al. Clinical corre-lates of NRAS and BRAF mutations in primary humanmelanoma. Clin Cancer Res, 2011, 17(2): 229-235.
  • 4Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF genein human cancer. Nature, 2002, 417(6892): 949-954.
  • 5Brose MS, Volpe P,Feldman M, et al. BRAF and RAS mutationsin human lung cancer and melanoma. Cancer Res, 2002, 62(23): 6997-7000.
  • 6Goel VK, Lazar AJ, Wameke CL, et al. Examination of mutationsin BRAF, NRAS, and PTEN in primary cutaneous melanomajInvest Dermatol, 2006, 126(1): 154-160.
  • 7Dhomen N,Marais R. BRAF signaling and targeted therapies inmelanoma. Hematol Oncol Clin North Am, 2009, 23 (3): 529-545.
  • 8朱琰琰,斯璐,迟志宏,崔传亮,盛锡楠,李思明,韩梅,郭军.中国黑色素瘤患者BRAF基因突变分析[J].临床肿瘤学杂志,2009,14(7):585-588. 被引量:17
  • 9郭芳,康晓静.BRAF、NRAS癌基因与恶性黑素瘤的研究[J].国际皮肤性病学杂志,2012,38(1):48-50. 被引量:3

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部